Ann M. Hanly, EVP & Chief Technology Officer at Vir Biotechnology, Inc. (VIR), sold 24,592 shares at $10.05 ($247K) on 2024-02-22, disclosed to the SEC on 2024-02-26.
Scheduled sale ($247k) by EVP & Chief Technology Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.05 | 12,296 | $124K | 50.0% |
| 2 | $10.05 | 12,296 | $124K | 50.0% |
| Total | $10.05 avg | 24,592 | $247K | 100% |
| Filing → |
| VIR | SELL | 2023-03-31 | $120K | — | Filing → |
| VIR | SELL | 2023-02-24 | $120K | — | Filing → |
| VIR | SELL | 2022-03-31 | $138K | — | Filing → |